personalized vaccines not attractive pharmaceutical companies introducing genomic component manufacturing complicated profitable says add degree uncertainty new possible patients wary vaccines concerned personalized inoculations public health track record years better making pure safer vaccines says director children hospital philadelphia sure initially met level distrust met current science poland optimistic deep schism people believe vaccines people not interesting groups highly attracted work says drives vaccine fears notes knowledge vaccines not work rare occasions cause effects guillain barre syndrome develops million people receive seasonal influenza vaccine vaccinomics actually able predict need vaccine doses need likely effect says power human health undeniable melinda